Psyched Wellness Completes Initial Data Review to Determine Clinical Path for Muscimol

Shares :


Toronto, Ontario–(Newsfile Corp. – January 14, 2021) –  Psyched Wellness Ltd.(formerly Duncan Park Holdings Corporation) (CSE: PSYC) (OTCQB: DCNPF) (FSE: 5U9) (the “Company” or “Psyched“), a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce that it has completed the first step in identifying the medicinal potential of Muscimol for various mental and physical health issues. 

The research was led by Psyched Wellness’s board member and head of the Company’s scientific committee, Prof. David Nutt. Prof. Nutt is a is a psychiatrist at the Edmond J. Safra Professor of Neuropsychopharmacology in the Division of Brain Science, Dept. of Medicine, Hammersmith Hospital, Imperial College London and is the Chair of the Scientific Advisory Board for COMPASS Pathways.

The study was initiated to compile and review all the scientific papers discussing Muscimol in order to provide the scientific evidence to support the thesis of using Muscimol as a potential treatment for various mental and physical health issues. 

Prof. David Nutt, Board member & head of the company’s scientific committee says, “As an orally active selective agonist at the newly discovered extra-synaptic GABA-A receptor, Muscimol offer exciting opportunities for new medicine development in conditions such as insomnia and sleep disorders, pain and pre-menstrual syndrome.”

David Shisel, COO of the company says: “We are very excited to share this development, completing this research will help the company determine what ailments will be the focus of our research with the goal of taking it to a full clinical trial.”

Sign up for MORE news updates !

This article is written and published by The Cannabis Stock

Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best articles and news on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result. The Cannabis Stock are engaged in the business of marketing and advertising companies

The Cannabis Stock and its employees may from time to time own shares of the companies named in the articles. All the facts reported by the cannabis stock are information that comes directly from the companies, from their website or on Sedar and are only published as information.

Click on a star to rate this article !

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Shares :